They argue that access to the Coronavirus Vaccine is a human rights issue and without the vaccine, the lives and livelihood … [26], Timelines for conducting clinical research – normally a sequential process requiring years – are being compressed into safety, efficacy, and dosing trials running simultaneously over months, potentially compromising safety assurance. [522] Early results suggest protection to the UK variant from the Pfizer and Moderna vaccines. [528], On 6 February 2021, the Financial Times reported that provisional trial data from a study undertaken by South Africa's University of the Witwatersrand in conjunction with Oxford University demonstrated reduced efficacy of the Oxford–AstraZeneca COVID-19 vaccine against the 501.V2 variant. The AstraZeneca vaccine is based on a non-replicating viral vector. Individual country reporting frequency varies. [92], These vaccines are examples of non-replicating viral vectors, using an adenovirus shell containing DNA that encodes a SARS‑CoV‑2 protein. These spikes let the coronavirus latch onto cells in our body. This whole process also depends on COVID-19 still being around. [44] The WHO's April 2020 "R&D Blueprint (for the) novel Coronavirus" documented a "large, international, multi-site, individually randomized controlled clinical trial" to allow "the concurrent evaluation of the benefits and risks of each promising candidate vaccine within 3–6 months of it being made available for the trial." [551] While the purchasing contracts with vaccine manufacturers remain secret, they do not contain liability exemptions even for side-effects not known at the time of licensure. The development and implementation of a safe and effective COVID-19 immunization program is a key component to Newfoundland and Labrador’s COVID-19 response. Here's the latest on the top candidates. The COVID-19 outbreak in China was first reported publicly on December 31, 2019. When the body’s immune system sees the spike protein, it makes antibodies to try to protect the body from infection. [527], In January, Johnson & Johnson, which held trials for its Ad26.COV2.S vaccine in South Africa, reported the level of protection against moderate to severe COVID-19 infection was 72% in the United States and 57% in South Africa. Find COVID-19 research information and resources by topic from NIH institutes and centers. Here are some key areas of COVID-19 vaccine development, review and authorization: Careful testing. [80][24][30] Vaccine platforms in development may improve flexibility for antigen manipulation and effectiveness for targeting mechanisms of COVID‑19 infection in susceptible population subgroups, such as healthcare workers, the elderly, children, pregnant women, and people with existing weakened immune systems. What physicians need to know about vaccine development webinar. Vaccine Development for COVID-19 and Infectious Diseases Research Tools and Resources Since the genetic sequence of SARS-CoV-2 was identified in January 2020, a global effort has been underway to develop a vaccine to combat the COVID-19 pandemic. ", "A COVID-19 vaccine will need equitable, global distribution", "COVID-19 pandemic reveals the risks of relying on private sector for life-saving vaccines, says expert", "Oxford, AstraZeneca COVID-19 deal reinforces 'vaccine sovereignty, "Here's why the WHO says a coronavirus vaccine is 18 months away", "Ensuring global access to COVID‑19 vaccines", "WHO 'backed China's emergency use' of experimental Covid-19 vaccines", "Russia Is Slow to Administer Virus Vaccine Despite Kremlin's Approval", "Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine", "Exclusive: Pfizer CEO Discusses Submitting the First COVID-19 Vaccine Clearance Request to the FDA", "Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine", "Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine", "UK medicines regulator gives approval for first UK COVID-19 vaccine", "U.K. Approves Pfizer Coronavirus Vaccine, a First in the West", "Covid Pfizer vaccine approved for use next week in UK", "Questions and Answers: COVID-19 vaccination in the EU", "Bahrain second in the world to approve the Pfizer/BioNTech Covid-19 vaccine", "UAE: Ministry of Health announces 86 per cent vaccine efficacy", "F.D.A. COVID-19 Research. [519] Trials indicate many vaccines developed for the initial strain have lower efficacy for some variants against symptomatic COVID-19. The trial location also affects the reported efficacy because different countries have different prevalences of SARS-CoV-2 variants. As the number of confirmed COVID-19 cases continues to skyrocket, healthcare researchers around the world are working tirelessly to discover new life-saving medical innovations. [54][57], In February 2020, the WHO said it did not expect a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the causative virus, to become available in less than 18 months. ... Peter Doshi has been pursuing the public release of COVID-19 vaccine trial protocols and access to raw data for all COVID-19 products. Indian government backing for COVID-19 vaccine development was made clear by India’s health minister Harsh Vardhan through an announcement of a US$120 million grant for COVID-19 vaccine research at that meeting, through the BRICS Science, Technology, and Innovation Cooperation session. January 14, 2021. Yes. The urgency to create a vaccine for COVID‑19 led to compressed schedules that shortened the standard vaccine development timeline, in some cases combining clinical trial steps over months, a process typically conducted sequentially over years. ", "Bacille Calmette-Guérin (BCG) vaccination and COVID-19", "How flu vaccine effectiveness and efficacy are measured", "Principles of epidemiology, Section 8: Concepts of disease occurrence", "Adaptive designs in clinical trials: why use them, and how to run and report them", "Adaptive designs for clinical trials of drugs and biologics: Guidance for industry", "An international randomised trial of candidate vaccines against COVID-19: Outline of Solidarity vaccine trial", "WHO recommends two doses of Pfizer COVID-19 vaccine within 21–28 days", "WHO: Amid short supplies, vaccine doses can be 6 weeks apart", "COVID vaccine: Moderna shots can be 6 weeks apart, WHO says", "Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine", "Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers", "Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints", "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine", FDA Review of Efficacy and Safety of Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization Request, "Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization", "2 Companies Say Their Vaccines Are 95% Effective. Canada announced funding for 96 research vaccine research projects at Canadian companies and universities, with plans to establish a "vaccine bank" that could be used if another coronavirus outbreak occurs,[46] and to support clinical trials and develop manufacturing and supply chains for vaccines. Inactivated vaccines consist of virus particles that have been grown in culture and then are killed using a method such as heat or formaldehyde to lose disease producing capacity, while still stimulating an immune response. COVID-19 vaccine development: What's the progress? In the following article, PharmaNewsIntelligence explores the industry’s latest and most significant efforts to find a COVID-19 vaccine. U.S. Department of Health and Human Services, Coronaviruses | NIH: National Institute of Allergy and Infectious Diseases, https://nihrecord.nih.gov/2020/12/11/corbett-recounts-quest-covid-vaccine, https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19, COVID-19 Vaccine Development: Behind the Scenes. The University of Oxford, together with three partner sites in London, Southampton and Bristol, is to launch the first study to assess the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine. [57] By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. Meet the Black female scientist at the forefront of COVID-19 vaccine development. The scientists chose to focus on one “prototype” coronavirus and create a vaccine for it. Developing a vaccine and bringing it to market often takes many years. The effectiveness of a new vaccine is defined by its efficacy during clinical trials. Mask-wearing had not yet been recommended at the time of this event. Moderna targets producing 600 million doses and Convidicea 500 million doses in 2021. "[561] Edward Bergmark and Arick Wierson are calling for an global vaccination effort and wrote that the wealthier nations' "me-first" mentality could ultimately backfire, because the spread of the virus in poorer countries would lead to more variants, against which current vaccines could be less effective. It could put a generation of researchers at risk", "Pandemic vaccines are about to face the real test", "Fauci warns of 'anti-science bias' being a problem in US", "Vaccines: The Emergency Authorisation Procedure", "Moderna COVID-19 vaccine under rolling review process in Canada, EU", "Pfizer files for emergency use of coronavirus vaccine in U.S. – what about in Canada? [1] On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by 19 March, the global pharmaceutical industry announced a major commitment to address COVID-19. [93], As of January 2021, authorized vaccines of this type are the British Oxford–AstraZeneca COVID-19 vaccine,[94][95][96] Russian Sputnik V,[97] Chinese Convidicea, and the Johnson & Johnson COVID-19 vaccine. Safety has been a top priority as federal agencies work with vaccine manufacturers to develop and authorize a COVID-19 vaccine. By the second week of January 2020, researchers in China published the DNA sequence of SARS-CoV-2, the coronavirus that causes COVID-19. [39][40][41], Internationally, the Access to COVID-19 Tools Accelerator is a G20 and World Health Organization (WHO) initiative announced in April 2020. The pharmaceutical industry, in collaboration with the government and other entities, have fast tracked the development of a COVID-19 vaccines. This whole process also depends on COVID-19 still being around. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development puts North American entities having about 40% of the activity compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa. Every Vaccine and Treatment in Development for COVID-19. [139] The efficacy is the risk of getting the disease by vaccinated participants in the trial compared with the risk of getting the disease by unvaccinated participants. It comprises four pillars, each managed by two to three collaborating partners: Vaccines (also called "COVAX"), Diagnostics, Therapeutics, and Health Systems Connector. A report by Carnegie Endowment for International Peace cited the current poverty rate in Egypt as around 29.7 percent, which constitutes approximately 30.5 million people, and claimed that about 15 million of the Egyptians would be unable to gain access to the luxury of vaccination. As of February 2021[update], eleven vaccines are authorized by at least one national regulatory authority for public use: two RNA vaccines (the Pfizer–BioNTech vaccine and the Moderna vaccine), four conventional inactivated vaccines (BBIBP-CorV, Covaxin, CoronaVac, and CoviVac [ru]), four viral vector vaccines (Sputnik V, the Oxford–AstraZeneca vaccine, Convidicea, and the Johnson & Johnson vaccine), and one peptide vaccine (EpiVacCorona). Quotes from Experts: COVID-19 Vaccine Development . Having safe and effective COVID-19 vaccines available is important to help with the long-term management of COVID-19. Long-term storage temperature. Vaccine efficacy reflects disease prevention, a poor indicator of transmissibility of SARS‑CoV‑2 since asymptomatic people can be highly infectious. But that's not how the math works", "Albania to start COVID-19 immunisation with Pfizer vaccine in January – report", "Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer", "Bahrain becomes second country to approve Pfizer COVID-19 vaccine", "Drug and vaccine authorizations for COVID-19: List of applications received", "Pfizer vaccine approved for region but Health Ministry wants more info", "Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use", "Colombia regulator approves Pfizer-BioNTech vaccine for emergency use", "Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine", "Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria", "Iraq grants emergency approval for Pfizer COVID-19 vaccine", "Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine", "Jordan approves Pfizer-BioNTech Covid vaccine", "Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine", "Liechtenstein – COVID19 Vaccine Tracker", "Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges", "Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine", "FIRST VACCINES ARRIVE IN MONACO – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco", "Robust assessment ahead of Medsafe approval of vaccine", "North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts", "Oman issues licence to import Pfizer BioNTech Covid vaccine – TV", "Panama approves Pfizer's COVID-19 vaccine – health ministry", "PH authorizes Pfizer's COVID-19 vaccine for emergency use", "Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week", "Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021", "Singapore approves use of Pfizer's COVID-19 vaccine", "Suriname begins coronavirus vaccination campaign with donated doses", "Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland", Swiss Agency for Therapeutic Products (Swissmedic), "Dubai approves the Pfizer-BioNTech vaccine which will be free of charge", "Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines", "Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID", "FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine", "Vatican to offer coronavirus vaccine to residents and staff in early 2021", "In Vaticano parte il piano vaccinale anticovid", "Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process", "WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access", Australian Public Assessment Report for BNT162b2 (mRNA), "Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil", "Første vaccine mod COVID19 godkendt i EU", "COVID-19: Bóluefninu Comirnaty frá BioNTech/Pfizer hefur verið veitt skilyrt íslenskt markaðsleyfi", "Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use", "Malaysia's NPRA Approves Pfizer Covid-19 Vaccine", "Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted", "Status på koronavaksiner under godkjenning per 21.12.20", "Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use", "Serbia leads region in expecting COVID-19 vaccines within days", "First shipment of Pfizer-BioNTech vaccine arrives in Serbia", "S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program", "S. Korea approves Pfizer's COVID-19 vaccine amid immunization push", "An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19", "Sputnik V COVID-19 vaccine candidate appears safe and effective", "Russia focuses on freeze-dried vaccine doses as transport fix", "Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19", "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia", "Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus", "Sputnik-V from Russia arrives in India for clinal trials", "Clinical trial: 17 volunteers given Russia's Sputnik V Covid-19 vaccine in Pune", "Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela", "UAE begins trials of Russia's Sputnik V Covid-19 vaccine", "Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine", "Argentina has registered the Sputnik V vaccine based on Russian clinical trial data", "Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF", "Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV", "Belarus registers Sputnik V vaccine, in first outside Russia – RDIF", "Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19", "COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs", "Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF", "Guatemala to receive Russia's Sputnik vaccine in coming weeks", "Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine", "Honduras approves use of Sputnik V vaccine against COVID-19", "Iran approves Russian coronavirus vaccine Sputnik V", "Kazakhstan begins mass vaccination by Russian Sputnik V", "Laos declares Covid-19 vaccinations safe, more to be inoculated next week | The Star", "Lebanon authorises emergency use of Russia's Sputnik V vaccine", "Mexico, Germany warm to Russia's Sputnik V virus vaccine", "Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF", "Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF", "Myanmar registers Russia's Sputnik V COVID-19 vaccine", "Nicaragua approves Russian COVID-19 vaccine", "Govt okays Russian vaccine for 'emergency use, "Palestine has become the first country in the Middle East to register Sputnik V vaccine", "Paraguay approves Russia's Sputnik V vaccine: RDIF", "Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska", "San Marino buys the Sputnik vaccine: "First doses already in the next few days, "Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju", "Sri Lanka approves Russia's Sputnik V vaccine", "Sputnik V vaccine authorized in Tunisia", "UAE approves Russia's Sputnik vaccine for emergency use", "Uruguay to start covid 19 Vaccination in April 2021", "Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V", "Vietnam approves US, Russia Covid-19 vaccines for emergency use", "Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine", "Hungarian drug regulator approves Sputnik V vaccine: website", "Turkmenistan is the first in Central Asia to have registered "Sputnik V" vaccine", "Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use", "AstraZeneca & Serum Institute of India sign licensing deal for 1 million doses of Oxford vaccine", "Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries", "The world's hopes for a coronavirus vaccine may run in these health care workers' veins", "Covid-19: Oxford-AstraZeneca vaccine approved for use in UK", "A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19", "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK", "Trial of Oxford COVID-19 vaccine starts in Brazil", "Oxford COVID-19 vaccine final trials will be held in these 17 hospitals in India", "First doses of COVID-19 vaccine arrive in Afghanistan from India", "India donates 500,000 COVID vaccines to Afghanistan", "Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine", "Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India", "Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use", "Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine", "Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin", "La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19", "Ecuador approves use of AstraZeneca vaccine for COVID-19", "El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine", "Guyana gets first batch of COVID-19 vaccines; CARICOM Secretariat to get 100 doses", "Nurse administers first shot of AstraZeneca ( ChAdOx1 nCoV-19, ) vaccine to Brinnet Bernarai at Georgetown Public Hospital Corporation – PAHO/WHO | Pan American Health Organization", "India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other", "BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca", "Iraq approves Sinopharm, AstraZeneca vaccines", https://www.bbc.com/news/world-africa-56239136, https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first, "Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua | English.news.cn", "Mauritius begins vaccinating frontline health workers against covid-19", "Mexico approves AstraZeneca COVID-19 vaccine, minister says", "Myanmar launches nationwide COVID-19 vaccination program", "Nepal approves AstraZeneca COVID vaccine for emergency use – government statement", "Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria", "Pakistan approves AstraZeneca COVID-19 vaccine for emergency use", "Philippine regulator approves emergency use of AstraZeneca vaccine", https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax, "AstraZeneca and Moderna vaccines to be administered in Saudi Arabia", "Sri Lanka approves vaccine amid warnings of virus spread", "Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca", "Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca", "Oxford University/AstraZeneca vaccine authorised by UK medicines regulator", "Conditions of Authorisation for COVID-19 Vaccine AstraZeneca", "Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress", "Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca", "AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO", "AstraZeneca coronavirus vaccine approved for use in Australia by TGA", "TGA provisionally approves AstraZeneca's COVID-19 vaccine", "Regulatory Decision Summary – AstraZeneca COVID-19 Vaccine", "COVID-19 Vaccine AstraZeneca: Pending EC decision", "EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU", "European Commission authorises third safe and effective vaccine against COVID-19", "Malaysia's NPRA Approves AstraZeneca, Sinovac Covid-19 Vaccines", "Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use", "S. Korea approves AstraZeneca's COVID-19 vaccine for all adults", "South Korea approves AstraZeneca COVID-19 vaccine", "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial", "China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says", "A Chinese Covid-19 Vaccine Has Proved Effective, Its Maker Says", "A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above", "Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)", "Bahrain allows Sinopharm COVID-19 vaccine candidate use in frontline workers", "Argentina approves Sinopharm COVID-19 vaccine for emergency use", "Bolivia begins inoculation with Sinopharm jabs | The Star", "Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine", "Dominica: Melissa Skerrit receives the Sinopharm COVID-19 vaccine", "Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua | English.news.cn", "Sinopharm vaccine rollout starts this weekend", "Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU", "Iran Launches Phase Two of Mass Inoculation Campaign", "First batch of Chinese Sinopharm vaccine arrives in Jordan", "China donates 50,000 doses of Sinopharm vaccine to Lebanon | News , Lebanon News | THE DAILY STAR", "Macau receives first batch of COVID-19 vaccines", "Covid-19: Morocco authorizes use of the Sinopharm vaccine", "Mozambique expects to vaccinate 16 million against coronavirus by 2022", "China's Shinopharm vaccine gets emergency use authorisation in Nepal", "Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use", "Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources", "Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm", "Serbia Becomes First European Nation To Use China's Sinopharm Vaccine", "Venezuela approves use of China's Sinopharm coronavirus vaccine", "Zimbabwe starts administering China's Sinopharm vaccines", "Bahrain approves China's Sinopharm coronavirus vaccine", "China approves Sinopharm coronavirus vaccine, the country's first for general use", "President Ramkalawan and First Lady receives second dose SinoPharm Vaccine", "Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl", "Coronavirus: UAE authorises emergency use of vaccine for frontline workers", "Sinovac says COVID-19 vaccine effective in preventing hospitalization, death", "Covid: What do we know about China's coronavirus vaccines?
Check List Aeromodelisme, Argumentaire Isolation 1 Euro, Robin Hood The Rebellion, Eso Electric Set, Tableau Pour Salon, Bac Sti2d Pour Devenir Architecte, Rue Sainte-catherine Magasins Horaires, Ccf Sciences Cap 2019, Accident Anglet Aujourd'hui,